NANCY RICHMOND: Open Payments
NPI 1770903098 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,282 in 266 payments from 23 companies in 2025. Trend: 2023 $3,690 · 2024 $6,581 · 2025 $4,282
Food & beverage: $4,282
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $708 |
| Amgen Inc. | 25 | $508 |
| LEO Pharma Inc. | 15 | $316 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $284 |
| Galderma Laboratories, L.P. | 32 | $262 |
| Incyte Corporation | 11 | $259 |
| Organogenesis Inc. | 10 | $245 |
| PFIZER INC. | 19 | $219 |
| UCB, Inc. | 8 | $207 |
| Lilly USA, LLC | 13 | $184 |
Products named: OTEZLA, SKYRIZI, DUPIXENT, ADBRY, ILUMYA, RINVOQ, OPZELURA, CIBINQO.
Industry payments across SC — which companies pay providers there.
